Albinterferon Alfa-2B Completed Phase 2 Trials for Chronic Hepatitis C Virus (HCV) Infection Treatment

Indications	Status	Purpose	Phase
DBCOND0057091 (Chronic Hepatitis C Virus (HCV) Infection)	Completed	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT00115908	A Study of Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1	Albinterferon Alfa-2B (DB05396) Ribavirin (DB00811)
NCT00656006	A Study of Albuferon With Ribavirin in Interferon Alfa Naive Subjects With Chronic Hepatitis C Genotype 2 or 3	Albinterferon Alfa-2B (DB05396) Ribavirin (DB00811)